Dopamine, Reward Learning and Sex Hormones

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hormonal ChangesMenstrual Cycle
Interventions
DRUG

Levodopa administration

To boost dopamine levels 150mg/37.5 mg L-DOPA/benserazide will be administered in line with recent studies (Kroemer et al., 2019). Maximum plasma concentration of Madopar occur \~60 minutes after drug administration. Participants will start the Effort Allocation Task 45 minutes after Levodopa administration.

DRUG

Placebo administration

Placebo tablets will be administered as the placebo-controlled condition.

Trial Locations (1)

72076

RECRUITING

Department of Psychiatry & Psychotherapy, University of Tübingen, Tübingen

Sponsors
All Listed Sponsors
collaborator

German Research Foundation

OTHER

collaborator

Uppsala University

OTHER

lead

University Hospital Tuebingen

OTHER